IP Library Granted Patent US 11,116,810
Granted Patent B2
US 11,116,810 · App. 14/437,996 · Granted Sep 14, 2021

Methods for treatment of skin and skin appendages with a linseed extract as an active agent activating the synthesis of antimicrobial peptides

Inventors: Jean-Marie Botto (Garbejaire, FR); Nouha Domloge (Valbonne, FR); Frederique Portolan (Valbonne, FR)
Assignee: ISP INVESTMENTS LLC
A61K36/55A61K8/645A61K8/9789A61K9/0014A61Q17/005A61Q19/00A61Q19/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,116,810
App. No.
14/437,996
Granted
Sep 14, 2021
Kind
B2
Abstract

Methods for the treatment of irritations of the skin and skin appendages caused by microbial stresses are disclosed. The methods include providing a composition comprising a linseed extract, obtained from hydrolysis of linseed proteins, as an active antimicrobial agent in a physiologically acceptable medium, and topically applying the linseed extract onto the skin in need thereof. The methods may be useful in the cosmetic and pharmaceutical field and, more particularly, in the field of dermatology. Cosmetic methods for reinforcing the chemical barrier function of healthy and/or sensitive skin and skin appendages are also disclosed that include the same or similar composition and steps.

Claims (7)

1. A method for the treatment of irritations of the skin and skin appendages caused by microbial stresses by increasing an expression level of defensin and/or cathelicidin antimicrobial peptides without causing a toxic or allergic reaction of the skin, the method comprising:

providing a composition comprising a linseed extract, obtained from hydrolysis of linseed proteins, and comprising at least 1.5 to 3.5 g/l of peptide compounds by weight of dry extract, 0.3 g/l or less of sugar by weight of dry extract and includes essentially peptide compounds having a molecular weight below 5 kDa, for pharmaceutical use, as an active antimicrobial agent in a physiologically acceptable medium; and

topically applying an effective amount of the linseed extract onto irritated skin of a subject in need twice daily for 24 or 48 hours, thereby increasing the expression level of defensin and/or cathelicidin antimicrobial peptides, and resulting in the treatment of irritations of the skin and skin appendages caused by microbial stresses.

2. The method of claim 1 , wherein the method maintains the equilibrium and favorable conditions of the ecosystem of the commensal microflora of the skin, and reinforces the chemical barrier function of sensitive skin and skin appendages, without causing a toxic or allergic reaction of the skin.

3. The method according to claim 1 , comprising topically applying an effective amount of the composition to reduce the imbalance of the commensal microbial flora of the skin and skin appendages.

4. The method according to claim 1 , wherein the composition includes the linseed extract at a concentration of between 0.05% and about 5%.

5. The method according to claim 1 , wherein, after dilution in a physiologically acceptable solvent, the linseed extract contains between 1.5 to 3.5 g/l of peptide compounds by weight of dry extract and 0.3 g/l or less of sugar by weight of dry extract.

Assignments (3)
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded May 24, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 042560/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2015
From: BOTTO, JEAN-MARIE; DOMLOGE, NOUHA; PORTOLAN, FREDERIQUE
To: ISP INVESTMENTS INC.
Reel/Frame 035481/0477 →
Cited By (1)
US 12,539,324